Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
217.00    10.00 (4.83%)
Bid:
211.00
Ask:
216.00
Spread: 5.00 (2.37%)
Market Cap: £114.57m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Trading Update

30 Oct 2018 07:00

RNS Number : 5809F
Microgen PLC
30 October 2018
 

 

microgen

www.microgen.com

 

30 October 2018

 

TRADING UPDATE

Microgen plc (LSE: MCGN) has continued to make good progress in the second half of the year.

Aptitude Software has achieved further success with its strategically important Aptitude Insurance Calculation Engine ('AICE'), an application which enables insurers to address the requirements of IFRS 17, an accounting standard focussed on insurance contracts and effective for accounting periods commencing on 1 January 2021. Building on the previously announced new business contracts for AICE in the first half of the year, in September the application was licenced to an existing Aptitude Accounting Hub user, a major global reinsurer headquartered in Europe, demonstrating the opportunity to increase Aptitude Software's footprint within existing clients as the suite of Aptitude Software's applications grows. The business has a number of additional very well qualified material opportunities for AICE in Asia, Europe and North America.

Aptitude Software has also made further progress with its Aptitude Lease Accounting Engine ('ALAE'), an application which allows organisations to address the requirements of IFRS 16 / ASC 842, the new lease accounting standards effective for accounting periods commencing on or after 1 January 2019. A number of new business sales for this application, provided as Software as a Service, have been completed in recent months. The leverage of the cloud platform acquired with the 2017 RevStream acquisition to Aptitude Software's core applications continues to be of great benefit to the business. RevStream sales activity remains strong with further sales expected in 2018 to build on the new business successes for this application in the first half of the year.

Microgen Financial Systems has achieved new business success for its leading Microgen 5Series application focussed on the Trust & Fund Administration market. New clients have been secured in both the Caribbean and Europe in the second half of the year with a number of further opportunities being progressed.

The Board expects the Group to meet management expectations for 2018. The outcome has only a limited amount of dependency on new business to be won during the remainder of the year. 

The Board further announces that Simon Baines has stepped down with immediate effect as Chief Executive Officer of Microgen Financial Systems, a board position of Microgen plc. Simon Baines will leave the employment of the Group in April 2019 to pursue other opportunities.

Microgen Financial Systems, as one of the Group's two software businesses, contributed 29% of Microgen plc's 2017 revenue. Philip Wood, Chief Financial Officer of Microgen plc, will assume the role of Acting Chief Executive Officer of Microgen Financial Systems whilst a long term successor for the role is identified for this business. Tom Crawford continues in his role as Chief Executive Officer of the Group's Aptitude Software business.

Information in relation to payments to be made to Simon Baines will be included in a statement on the Company's website in accordance with Section 430(2B) of the Companies Act 2006.

Ivan Martin, Non-Executive Chairman of Microgen plc, commented:

'Simon Baines joined the Group in 2010 to lead the Microgen Financial Systems business. Under his leadership Microgen Financial Systems has developed into a leading provider of software to the Trust & Fund Administration market, overseeing five acquisitions during his tenure. The Board thanks Simon for his contribution to the business and wishes him well for the future.'

Contacts

Ivan Martin, Chairman 0203 880 7100

Philip Wood, Chief Financial Officer 0203 880 7100

Junya Iwamoto, Investec 0207 597 5970

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMMMZGVLLGRZM
Date   Source Headline
18th May 20157:00 amRNSAGM Trading Update
29th Apr 201512:26 pmRNSHolding(s) in Company
30th Mar 20155:49 pmRNSBlocklisting Interim Review
19th Mar 20157:00 amRNSReturn of Value and Listing of New Ordinary Shares
18th Mar 201511:23 amRNSResults of General Meeting
6th Mar 201512:22 pmRNSHolding(s) in Company
26th Feb 20153:39 pmRNSHolding(s) in Company
25th Feb 20152:26 pmRNS2014 Final Dividend
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review
15th Sep 20145:04 pmRNSHolding(s) in Company
1st Sep 20147:00 amRNSTotal Voting Rights
21st Jul 20147:00 amRNSInterim Results
14th Jul 20143:00 pmRNSNotice of Results
1st Jul 201412:11 pmRNSBlocklisting Interim Review
20th Jun 20148:10 amRNSDirector Declaration
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
11th Jun 20149:34 amPRNForm 8 (OPD) Microgen plc
5th Jun 20142:20 pmRNSForm 8.3 - Microgen Plc
5th Jun 201412:13 pmRNSForm 8.3 - Microgen PLC
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
2nd Jun 201410:50 amRNSTotal Voting Rights
30th May 201410:23 amBUSForm 8.3 - Microgen Plc
29th May 201410:08 amRNSRule 8.3 opening position disclosure
27th May 20142:39 pmPRNForm 8.3 - Microgen plc
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
27th May 201411:44 amRNSForm 8.3 - Microgen Plc
23rd May 20145:22 pmRNSForm 8.3 - Microgen plc
23rd May 201410:22 amRNSForm 8.3 - Microgen Plc
21st May 20143:29 pmRNSForm 8.3 - [Microgen plc]
21st May 20143:04 pmRNSForm 8.3 - Microgen Plc
21st May 20142:13 pmRNSForm 8.3 - MICROGEN PLC
21st May 20141:10 pmRNSForm 8.3 - Microgen Plc
21st May 201411:48 amBUSForm 8.3 - Microgen Plc
21st May 201411:46 amRNSForm 8.3 - [MICROGEN PLC]
21st May 201411:21 amRNSForm 8.3 - MICROGEN ORD GBP0.05
21st May 20149:00 amRNSResponse to Microgen
20th May 201412:39 pmRNSFurther Statement Re Elektron Technology Plc
20th May 201410:20 amRNSStatement re Elektron Technology

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.